These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15559553)

  • 1. Efficacy of dapsone in an adolescent with chronic autoimmune thrombocytopenia.
    Alliot C; Barrios M
    Therapie; 2004; 59(4):479-80. PubMed ID: 15559553
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful use of dapsone in refractory pregnancy-associated idiopathic thrombocytopenic purpura.
    Lush R; Iland H; Peat B; Young G
    Aust N Z J Med; 2000 Feb; 30(1):105-7. PubMed ID: 10800898
    [No Abstract]   [Full Text] [Related]  

  • 3. Dapsone for chronic autoimmune thrombocytopenic purpura: a report of 66 cases.
    Godeau B; Durand JM; Roudot-Thoraval F; Tennezé A; Oksenhendler E; Kaplanski G; Schaeffer A; Bierling P
    Br J Haematol; 1997 May; 97(2):336-9. PubMed ID: 9163598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dapsone for refractory chronic idiopathic thrombocytopenic purpura.
    Hernández F; Linares M; Colomina P; Pastor E; Cerveró A; Pérez A; Perella M
    Br J Haematol; 1995 Jun; 90(2):473-5. PubMed ID: 7794776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dapsone for idiopathic thrombocytopenic purpura.
    Linares M; Cervero A; Pastor E; Colomina P
    Am J Hematol; 1994 Aug; 46(4):371-2. PubMed ID: 8037195
    [No Abstract]   [Full Text] [Related]  

  • 6. Dapsone for autoimmune thrombocytopenic purpura.
    Godeau B; Oksenhendler E; Bierling P
    Am J Hematol; 1993 Sep; 44(1):70-2. PubMed ID: 8342569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of relevance of the acetylator status on dapsone response in chronic autoimmune thrombocytopenic purpura.
    Le Louët H; Ruivart M; Bierling P; Duche JC; Godeau B
    Am J Hematol; 1999 Dec; 62(4):251-2. PubMed ID: 10589083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age old dapsone in the treatment of idiopathic thrombocytopenic purpura--a case report with review.
    Kundu R; Sethi N; Ghose A; Chaudhary R
    Am J Ther; 2013; 20(6):e723-5. PubMed ID: 21822117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dapsone treatment in a girl with severe chronic thrombocytopenic purpura. Does it work? Do not touch it!
    Pusiol A; Nocerino A; Passone E; Tenore A
    Minerva Pediatr; 2012 Oct; 64(5):545-7. PubMed ID: 22992536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How does dapsone work in immune thrombocytopenia? Implications for dosing.
    Hill QA
    Blood; 2015 Jun; 125(23):3666-8. PubMed ID: 26045596
    [No Abstract]   [Full Text] [Related]  

  • 11. Adult refractory chronic idiopathic thrombocytopenic purpura: can dapsone be proposed as second-line therapy?
    Radaelli F; Calori R; Goldaniga M; Guggiari E; Luciano A
    Br J Haematol; 1999 Mar; 104(3):641-2. PubMed ID: 10086809
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination Therapy of Azathioprine+ Dapsone as Effective Second Line Agents for the Treatment of Chronic Immune Thrombocytopenic Purpura.
    Bm S; Toshniwal M; Bhattacharya M; Jakkal D
    J Assoc Physicians India; 2020 Jan; 68(1):99. PubMed ID: 31979921
    [No Abstract]   [Full Text] [Related]  

  • 13. Dapsone therapy for children with immune thrombocytopenic purpura.
    Meeker ND; Goldsby R; Terrill KR; Delaney KS; Slayton WB
    J Pediatr Hematol Oncol; 2003 Feb; 25(2):173-5. PubMed ID: 12571474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dapsone for immune thrombocytopenic purpura in children and adults.
    Patel AP; Patil AS
    Platelets; 2015; 26(2):164-7. PubMed ID: 24512442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dapsone for primary immune thrombocytopenia in adults and children: an evidence-based review.
    Rodrigo C; Gooneratne L
    J Thromb Haemost; 2013 Nov; 11(11):1946-53. PubMed ID: 23927583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura.
    Vancine-Califani SM; De Paula EV; Ozelo MC; Orsi FL; Fabri DR; Annichino-Bizzacchi JM
    Platelets; 2008 Nov; 19(7):489-95. PubMed ID: 18979360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of dapsone as second line therapy for adult immune thrombocytopenia: A retrospective study of 42 patients.
    Estève C; Samson M; Guilhem A; Nicolas B; Leguy-Seguin V; Berthier S; Bonnotte B; Audia S
    PLoS One; 2017; 12(10):e0187296. PubMed ID: 29084292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is dapsone still relevant in immune thrombocytopenia in resource limited settings?
    Dalal P; Gulia M; Gupta M; Tahlan A
    BMJ Case Rep; 2019 Dec; 12(12):. PubMed ID: 31862814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a novel pyridylsulphonyl thiazole derivative, FR115092, on autoimmune and mitomycin C-induced thrombocytopenia in mice.
    Nishigaki F; Tsujimoto S; Inami M; Matsumoto S; Naoe Y; Kawamura I; Manda T; Shimomura K
    J Pharm Pharmacol; 1999 Jul; 51(7):857-65. PubMed ID: 10467963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dapsone for chronic idiopathic thrombocytopenic purpura in children and adults--a report on 90 patients.
    Damodar S; Viswabandya A; George B; Mathews V; Chandy M; Srivastava A
    Eur J Haematol; 2005 Oct; 75(4):328-31. PubMed ID: 16146539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.